Comparative study of ibuprofen solubility in synthetic and natural lipid vehicles

Dhaka University Journal of Pharmaceutical Sciences

Volumn 10, Issue 1, 2011, Pages 65-66

  Roni, Monzurul Amin ^a   Jalil, Reza Ul ^a  

^a UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIS OIL; CASTOR OIL; DRUG VEHICLE; IBUPROFEN; MEDIUM CHAIN TRIACYLGLYCEROL; METHANOL; OLEIC ACID; OLIVE OIL; PROPYLENE GLYCOL; PROPYLENE GLYCOL MONOCAPRYLATE; SOYBEAN OIL; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; DILUTION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MEGADOSE; DRUG SOLUBILITY; DRUG SOLUTION; ROOM TEMPERATURE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84857959162     PISSN: 18161820     EISSN: 18161839     Source Type: Journal    
DOI: 10.3329/dujps.v10i1.10018     Document Type: Article

References (7)

1. Ahn, Y.S., Song, I.H., Kang, B.K., Kim, M.S., Cho, S.H., Rhee, lM., Lee, H.B. and Khang, G. 2004. Preparation and characterization of liquefied Ibuprofen using selfmicroemulsion drug delivery system (SMEDDS). J. Kor. Pharrn. Sci. 34, 35-42.
2. Newa, M., Bhandari, K.H., Kim, J.O.I.M.J.S., Kim, J.A., Yoo, B.K., Woo, J.S., Choi, H.G. and Yong, C.S. 2008. Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems. Chem. Pharm. Bull. 56, 569-574.
3. Murtha, J.L. and Ando, H. Y 1994. Synthesis of the cholesteryl ester prodrugs cholesteryl ibuprofen and cholesteryl flufenamate and their formulation into phospholipid micro-emulsion. J. Pharm. Sci. 83, 1222-1228.
4. Ghorab, M.K. and Adeyeye M.C. 2001. Enhancement of ibuprofen dissolution via wet granulation with betacyclodextrin. Pham. Dev. Tech. 6, 305-314.
5. Adeyeye, C.M. and Price, I.C. 1994. Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies. Pharm. Res. 1, 575-579.
6. Tyler, V.E., Brady, L.R. and Robbers, J.E. 1981. Pharmacognosy. Lea & Febiger, Philadelphia, 9th ed. p. 89.
7. Bangladesh National Formulary 2006. Directorate of Drug Administration, p. 302.